ea0081p533 | Adrenal and Cardiovascular Endocrinology | ECE2022
Ceccato Filippo
, Torchio Marianna
, Tizianel Irene
, Barbot Mattia
, Sabbadin Chiara
, Betterle Corrado
, Scaroni Carla
Context: Fludrocortisone (FC) is the mineralocorticoid (MC) replacement treatment for patients with primary adrenal insufficiency (PAI). Objective: To explore the dose of FC treatment and its relationship with glucocorticoid therapy, sodium, potassium, renin and clinical parameters. Design: Longitudinal study.Setting: Monocentric cohort.Patients: Data of 193 patients with PAI (130 autoi...